Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Further Reading from MarketBeat.com The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Written by Chris Markoch. Article Published: 1/18/2026. 
Key Points - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. Investors typically look for companies with disruptive technologies, exposure to emerging trends, or compelling turnaround stories. Many of these firms will never survive or scale, but if one succeeds, returns can be significant. For investors who find comfort in crowd interest, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks, ranked by the number of MarketBeat subscribers following each company. While popularity isn't a guarantee of success, it can provide added conviction for some investors.
This isn't just another gold investing book—it's a survival playbook written by a former CIA officer trained to stay alive when systems collapse.
In Operation Gold Rush, Jason Hanson reveals how gold and silver saved his life—and how they could protect yours in the next crisis. You'll learn how to hide gold like a covert operative, secure your 401(k) in physical assets, and prepare for grid failures, economic collapse, or worse.
Click here to get your free copy + up to $10,000 in free silver while supplies last. Some market participants call any stock trading at $5 or less a penny stock. This screener uses the traditional definition: stocks priced below $1. These names are highly volatile — do your own research and know your risk tolerance before initiating a position. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases such as influenza, norovirus, and COVID-19. Unlike traditional injectable vaccines, Vaxart's tablet-based platform aims to simplify distribution and improve global accessibility. The bull case for Vaxart rests on its novel delivery approach. If the company secures FDA approval and can scale manufacturing and distribution, its oral vaccines could reduce logistical barriers to mass immunization and create licensing opportunities. Positive trial results or a commercial partnership could sharply improve sentiment and valuation from the stock's current low base. Clinical risk is the primary hurdle. Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also limits visibility. For now, Vaxart is more of a long-term, speculative bet on platform validation than a play on near-term profitability. The MarketBeat analyst ratings show only one analyst covering VXRT, which is common for penny stocks but worth noting. The company has roughly 18% institutional ownership. On the positive side, short interest is around 2%, which may moderate some volatility. Microvision: Developing Cost-Effective LiDAR Units For Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure, and industrial sensing. Its hardware and software solutions enable precise 3D mapping required for self-driving and advanced driver-assistance systems (ADAS). Microvision focuses on compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case for Microvision depends on the continued push toward vehicle automation and the potential for partnerships with major automotive manufacturers. If Microvision can demonstrate superior performance or clear cost advantages, it could secure supply agreements or licensing deals that materially improve revenue visibility. Its technology also has possible applications in robotics and smart cities, adding optionality to the growth story. Despite the promise, Microvision faces stiff competition from LiDAR companies such as Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ), and Ouster (NYSE: OUST). The path to profitability is uncertain, and delays in commercial adoption of LiDAR technology continue to frustrate investors. MVIS is covered by three analysts and has a consensus price target of $2.50 — about a 169% upside from its Jan. 15 closing price. However, Microvision has relatively low institutional ownership (around 30%) and high short interest (around 21%), which can contribute to significant volatility for long-term investors. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) sits at the intersection of artificial intelligence, data monetization, and digital asset management. The company helps organizations convert raw data into tradable, revenue-generating assets via its patented Datavault platform. By combining AI, blockchain, and analytics, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems may overlook. The bullish thesis for Datavault AI is its niche focus and scalability potential. As data becomes an increasingly valuable commodity, businesses — and potentially individuals — will seek ways to safely monetize digital information. Datavault's technology could benefit from broader AI adoption and growing emphasis on data sovereignty. Early traction or strategic partnerships could act as catalysts for investor confidence. Still, Datavault AI operates in a highly experimental space. The business model is evolving, and a path to meaningful revenue growth remains unproven. Institutional ownership is under 1%, and short interest exceeds 16% as of this writing. Investors considering DVLT should view it as a long-term, speculative position based on belief in data-as-an-asset innovation rather than a near-term earnings play.
| 
